MedPath

Study of anti-nausea drug metoclopramide easily nasogastric tube insertion compared with patients not receiving.

Not Applicable
Conditions
pain, discomfort and nausea associated with NG Tube insertion.
Complications of action on the digestive system
Registration Number
IRCT2015083023696N2
Lead Sponsor
Mazandaran University Of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
46
Inclusion Criteria

inclusion criteria:patient's willingness to participate in the study and obtain informed consent; Indications put nasogastric tube; Age over 18 years.
exclusion criteria:Lack of patient awareness; Patients with unstable hemodynamic status; Having nosebleeds during the study period; Having problems anatomical nose; Trauma patients; Hypersensitivity to metoclopramide; Medications interact with metoclopramide; Pregnancy;patients with nausea and vomiting will ; If more than two attempts for nasogastric tube insertion is done.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Discomfort during intubation. Timepoint: Zero minutes, 30 minutes, 60 minutes. Method of measurement: score pain, nausea, discomfort.;Nausea and vomiting. Timepoint: Zero minutes, 30 minutes, 60 minutes. Method of measurement: score pain, nausea, discomfort.;Pain. Timepoint: Zero minutes, 30 minutes, 60 minutes. Method of measurement: score pain, nausea, discomfort.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath